Immuron (IMRN) Other Non Operating Income (2018 - 2024)
Immuron (IMRN) recorded quarterly Other Non Operating Income of $48.5 billion in Q4 2024, up 6455318.51% quarter-over-quarter from -$750560.0 in Q4 2023, and up 6455318.51% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Other Non Operating Income (2018 - 2024) Analysis & Trends
Immuron's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $48.5 billion for Q4 2024.
- In Q4 2024, Other Non Operating Income rose 6455318.51% year-over-year to $48.5 billion; the TTM figure through Dec 2024 stood at $48.4 billion (up 5436627.81% YoY), while the FY2025 annual figure was $7896.2, up 143.62% from the prior year.
- Other Non Operating Income was $48.5 billion for Q4 2024 at Immuron, up from -$750560.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $48.5 billion in Q4 2024 to a low of -$750560.0 in Q4 2023.
- Historically, Other Non Operating Income has averaged $9.7 billion across 5 years, with a median of -$8736.3 in 2020.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income slumped 13689.24% in 2022, then surged 6455318.51% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at -$8736.3 in 2020, then soared by 89.13% to -$949.56 in 2021, then plunged by 13689.24% to -$130937.0 in 2022, then plunged by 473.22% to -$750560.0 in 2023, then surged by 6455318.51% to $48.5 billion in 2024.
- The last three Other Non Operating Income figures came in at $48.5 billion (Q4 2024), -$750560.0 (Q4 2023), and -$130937.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 48.45 Bn |
| Dec 31, 2023 | -750,560.00 |
| Dec 31, 2022 | -130,937.00 |
| Dec 31, 2021 | -949.56 |
| Dec 31, 2020 | -8,736.33 |
| Dec 31, 2019 | 443.30 |
| Dec 31, 2018 | 257,501.00 |